Nano drug aims to boost appetite and weight in pancreatic cancer patients

This study tests a new nano-formulation of megestrol acetate, a drug used to stimulate appetite and promote weight gain, in patients with advanced pancreatic cancer who suffer from anorexia-cachexia syndrome. The trial will enroll 56 patients and compare those receiving the nano-drug alongside standard chemotherapy to those receiving chemotherapy alone. The goal is to see if the nano-drug helps patients gain more than 5% of their body weight and improves their appetite and quality of life.